Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 318 participants.

Also called NCT04059913

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 318 participants (enrolled count) (from the registry)
Sponsor
  • Kyntra Bio Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04059913
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04059913. Randomized; no masking; primary purpose treatment. Start 2019-06-11 (actual); primary completion 2021-11-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease
Condition
CKD Anemia in Dialysis Participants
Intervention (Drug)
Roxadustat
Lead sponsor
Kyntra Bio (class: industry)

Record details

Record id
cardio:ct-nct04059913
Content hash
bfc010cd4bb8d5e8c4e37993c353da03ddbb25f20161ebc19ae8bb3f2d524c35